Koordinierungszentren für Klinische Studien bzw. Zentren für klinische Studien   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Berlin Germany (2005)

Organization Overview

First Clinical Trial
2005
NCT00141804
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

KKS Netzwerk

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenoma (Phase 2)

Adenoma, Villous (Phase 2)

Breast Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, T-Cell (Phase 2)

Lymphoma, T-Cell, Cutaneous (Phase 2)

Multiple Organ Failure (Phase 2)

Spinal Cord Injuries (Phase 2)

Syndrome (Phase 2)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 12